XOMA Corporation (XOMA)

[stocksablaze]

FYI Xoma's net income will increase at a rate of $400,000 per mo bc they are stopping gevokizumab and plan to sell data to big Pharma.
This points to a positive net income picture later this year! This is worth a heck of a lot more now then it was because of I like focus management to strip assets to make this company not only survive and come out stronger than it ever was down the road with its endocrine portfolio. nice!